Search by Drug Name or NDC
NDC 69097-0995-05 DILTIAZEM HYDROCHLORIDE 300 mg/1 Details
DILTIAZEM HYDROCHLORIDE 300 mg/1
DILTIAZEM HYDROCHLORIDE is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA, Inc.. The primary component is DILTIAZEM HYDROCHLORIDE.
MedlinePlus Drug Summary
Diltiazem is used to treat high blood pressure and to control angina (chest pain). Diltiazem is in a class of medications called calcium-channel blockers. It works by relaxing the blood vessels so the heart does not have to pump as hard. It also increases the supply of blood and oxygen to the heart. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 69097-0995-05Last Updated: 05/05/2024
MedLinePlus Full Drug Details: Diltiazem
Product Information
| NDC | 69097-0995 |
|---|---|
| Product ID | 69097-995_8da140e7-0298-4985-a4a1-f8dd5cbbfccd |
| Associated GPIs | |
| GCN Sequence Number | 051804 |
| GCN Sequence Number Description | diltiazem HCl TAB ER 24H 300 MG ORAL |
| HIC3 | A9A |
| HIC3 Description | CALCIUM CHANNEL BLOCKING AGENTS |
| GCN | 19185 |
| HICL Sequence Number | 000182 |
| HICL Sequence Number Description | DILTIAZEM HCL |
| Brand/Generic | Generic |
| Proprietary Name | DILTIAZEM HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | diltiazem hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/1 |
| Substance Name | DILTIAZEM HYDROCHLORIDE |
| Labeler Name | Cipla USA, Inc. |
| Pharmaceutical Class | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA216327 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69097-0995-05 (69097099505)
| NDC Package Code | 69097-995-05 |
|---|---|
| Billing NDC | 69097099505 |
| Package | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-995-05) |
| Marketing Start Date | 2023-06-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |